IMMX Latest Press Releases

-- May 22, 2026 --

Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock Globe Newswire 5:15 PM

-- May 21, 2026 --

Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock Globe Newswire 6:30 AM

-- April 9, 2026 --

Immix Biopharma to Participate in the Jefferies Global Healthcare Conference Globe Newswire 8:45 AM

-- March 30, 2026 --

Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones Globe Newswire 8:45 AM

-- March 3, 2026 --

Immix Biopharma to Participate in Upcoming Investor Conferences Globe Newswire 8:45 AM

-- January 28, 2026 --

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201 Globe Newswire 8:45 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software